Control of persistent asthma in Spain: Associated factors

Journal of Asthma

Volumn 45, Issue 9, 2008, Pages 740-746

  Díez, Javier De Miguel ^a   Barcina, Carlos ^b   Muñoz, Mercedes ^b   Leal, Manuel ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b ASTRAZENECA   (United Kingdom)

Author keywords

ACQ; Asthma; Control; Determinants

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; ANTHROPOMETRY; ARTICLE; ASTHMA; BODY MASS; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HABIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICIAN; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SMOKING; SOCIOECONOMICS; SPAIN;

EID: 55249093226     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802216783     Document Type: Article

References (42)

1. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, Fernández-Fau L, Villasante C. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol 1999; 35:159-166.
2. Plaza del Moral V, Álvarez Gutiérrez FJ, Casan Clará P, Cobos Barroso N, López Viña A, Llauger Rosselló MA, et al. Guía española para el manejo del asma (GEMA). Arch Bronconeumol 2003; 39 (suppl 5):1-42. Available from: http://www.gemasma.com
3. De Miguel Díez J. Farmacoeconomía en el asma y en la EPOC. Arch Bronconeumol 2005; 41:239-241.
4. Global initiative for asthma. Revision 2006. Available from: www.ginasthma.com
5. Gillissen A. Managing asthma in the real world. Int J Clin Pract 2004; 58:592-603.
6. Horn CR, Clark TJ, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84:67-70.
7. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-907.
8. Juniper EF, O'Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? Respir Med 2001; 95:319-323.
9. Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99:553-558.
10. Juniper EF, Bousquet J, Abetz L, Bateman ED, the GOAL committee. Identifying "well-controlled" and "not well-controlled" asthma using the asthma control questionnaire. Respir Med 2006; 100:616-621.
11. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807.
12. Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med 2002; 96:142-149.
13. Lai CK, De Guia, Kim YY, Kuo SH, Mukhopadhyay A, Soriano JB, et al. Asthma control in the Asia-Pacific region: the asthma insights and reality in Asia-Pacific study. J Allergy Clin Immunol 2003; 111:262-268.
14. Soriano JB, Rabe KF, Vermeire PA. Predictors of poor asthma control in European adults. J Asthma 2003; 40:803-813.
15. Lopez Viña A, Cimas JE, Diaz Sánchez C, Coria G, Vegazo A, Picado Valles C. A comparison of primary care physicians and pneumologists in the management of asthma in Spain: ASES study. Respir Med 2003; 97:872-881.
16. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114:40-47.
17. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6:13.
18. Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007; 7:8.
19. Vollmer WM. Assessment of asthma control and severity. Ann Allergy Asthma Immunol 2004; 93:409-414.
20. ENFUMOSA. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003; 22:470-477.
21. Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study: a large cohort of patients with severe or difficult to treat asthma. Ann Allergy Asthma Immunol 2004; 92:32-39.
22. Schatz M, Camargo CA. The relationship of gender to asthma prevalence, healthcare utilization, and medications in a large managed care organization. Ann Allergy Asthma Immunol 2003; 91:553-558.
23. Van Dellen QM, Stronks K, Bindels PJE, Öry FG, Bruil J, van Aalderen WMC, et al. Predictors of asthma control in children from different ethnic origins living in Amsterdam. Respir Med 2007; 101:779-785.
24. De Palo VA, Mayo PH, Friedman P, Rosen MJ. Demographic influences on asthma hospital admission rates in New York City. Chest 1994; 106:447-451.
25. Joseph CLM, Havstad SL, Ownby DR, Johnson CC, Tilley BC. Racial differences in emergency department use persist despite allergist visits and prescriptions filled for anti-inflammatory medications. J Allergy Clin Immunol 1998; 101:484-490.
26. Ray NF, Thamer M, Fadilliogle B, Gergen PJ. Race, income, urbanization and asthma hospitalizations in California: a small area study. Chest 1998; 113:1277-1284.
27. Miller JE. The effects of race/ethnicity and income on early childhood asthma prevalence and health care use. Am J Public Health 1999; 90:428-430.
28. Castro M, Schechtman KB, Halstead J, Bloomberg G. Risk factors for asthma morbidity and mortality in a large metropolitan city. J Asthma 2001; 38:625-635.
29. Eisner MD, Ackerson LM, Chi F, Kalkbrenner A, Buchner D, Mendoza G. Health-related quality of life and future health care utilization for asthma. Ann Allergy Asthma Immunol 2002; 89:46-55.
30. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. Chest 2005; 108:28-35.
31. Lieu TA, Quesenberry CP, Capra AM, Sorel ME, Martin KE, Mendoza GR. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics 1997; 100:334-341.
32. Sachtz M, Zeiger RS, Vollmer WM, Mosen D, Cook EF. Determinant of future long-term asthma control. J Allergy Clin Immunol 2006; 118:1048-1053.
33. Weiss ST, Shore S. Obesity and asthma: directions for research. Am J Respir Crit Care Med 2004; 169:963-968.
34. Hasler G, Gergen PJ, Ajdacic V, Gamma A, Eich D, Rössler W, et al. Asthma and body weight change: a 20-year prospective community study of young adults. Int J Obes (Lond) 2006; 30:1111-1118.
35. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000; 118:1315-1321.
36. Aaron SD, Fergusson D, Dent R. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125:2046-2052.
37. Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med 2006; 100:1139-1151.
38. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200.
39. Chalmers GW, MacLeod KJ, Little SA, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2001; 57:226-230.
40. Tonneson P, Pisinger C, Hvidberg S, Wennicke P, Bremann L, Westin A, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7:139-148.
41. Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X, on behalf of the ESCASE group. Respir Med 2007; 101:919-924.
42. Chanez P, Wenzel SE, Anderson GP, Anto JM, Bel EH, Boulet LP, Severe asthma in adults: what are the important questions? J Allergy Clin Immunol. 2007; 119:1337-1348.